Vorinostat is a potent histone deacetylase (HDAC) inhibitor approved for the treatment of cutaneous T-cell lymphoma and peripheral T-cell lymphoma, functioning through epigenetic modulation of gene expression.… Read more








Vorinostat is a potent histone deacetylase (HDAC) inhibitor approved for the treatment of cutaneous T-cell lymphoma and peripheral T-cell lymphoma, functioning through epigenetic modulation of gene expression. This category features a comprehensive range of high-quality reference standards essential for the rigorous analytical testing and quality control of this active pharmaceutical ingredient. Laboratories rely on these materials, including characterized process-related impurities and degradation products, to facilitate accurate impurity profiling and ensure compliance with regulatory standards. The collection also includes significant metabolites, such as the glucuronide derivative, alongside stable isotope-labelled compounds like deuterated and 13C-labelled analogs. These labelled standards are critical tools for mass spectrometry-based bioanalytical method validation, providing precise internal controls for quantification in complex biological matrices. Together, these compounds support the complete lifecycle of pharmaceutical development and routine analysis.